tokyo

Data Eraser Tool “DiskShredder ToGo” Achieves ADISA Product Assurance Certification to NIST 800-88

ADISA’s Research Centre, a UK-based independent test laboratory, certifies its first Japanese data erasure softwareTOKYO--(BUSINESS WIRE)--Personal Media Corporation (President &…

2 weeks ago

Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases

Hinge Bio to receive $10 million upfront and is eligible to receive $95 million for the SLE indication and additional…

2 weeks ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

September 29, 2025 19:30 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…

2 weeks ago

LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China

September 28, 2025 19:30 ET  | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Eisai…

2 weeks ago

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan

BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.  (NASDAQ: LNTH) and GE HealthCare…

3 weeks ago

Spider Labs Rebrands as Marketing Security Platform to Strengthen Digital Risk Protection

TOKYO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spider Labs Inc., provider of Spider AF, Japan’s No.1 ad fraud prevention tool…

4 weeks ago

Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs REMONY for Advanced Health Monitoring and Heatstroke Safety

TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM…

4 weeks ago

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732

HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…

4 weeks ago

Huawei Shares Industrial Challenges at the 2025 ICPC World Finals

BAKU, Azerbaijan, Sept. 10, 2025 /PRNewswire/ -- The St. Petersburg State University team has won the 2025 ICPC World Championship at the…

1 month ago